Raymond James Financial Services Advisors, Inc. Cel Sci Corp Transaction History
Raymond James Financial Services Advisors, Inc.
- $73.5 Billion
- Q3 2024
A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Cel Sci Corp stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 22,444 shares of CVM stock, worth $234,090. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,444
Previous 21,164
6.05%
Holding current value
$234,090
Previous $24,000
4.17%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding CVM
# of Institutions
13Shares Held
1.39MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY775KShares$8.08 Million0.0% of portfolio
-
Mai Capital Management526KShares$5.49 Million0.0% of portfolio
-
Raymond James & Associates St Petersburg, FL18.9KShares$196,8970.0% of portfolio
-
Hyperion Partners, LLC Berwyn, PA16.6KShares$173,1380.01% of portfolio
-
ETF Managers Group, LLC Summit, NJ14.5KShares$151,4640.0% of portfolio
About CEL SCI CORP
- Ticker CVM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,367,500
- Market Cap $452M
- Description
- CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...